Richard Collis

Richard Collis currently serves as Executive Medical Director and Senior Medical Director at Ultragenyx, focusing on global clinical development since October 2022. Prior experience includes roles as Senior Medical Director and Medical Director at Freeline from July 2021 to September 2022, and Medical Advisor at Sanofi from April 2018 to June 2021. Richard has also held clinical research and specialist registrar positions in cardiovascular medicine at UCL and St. James's Hospital Dublin, respectively, and completed basic specialist training in general internal medicine at the Royal College of Physicians of Ireland. Richard completed an MD in Inherited Cardiomyopathies from UCL, a Diploma in Pharmaceutical Medicine from the Faculty of Pharmaceutical Medicine, and earned MRCPI in Medicine from The Royal College of Physicians in Ireland. Richard obtained an MB BCh BAO in Medicine from the Royal College of Surgeons in Ireland.